{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T14:31:47Z","timestamp":1768746707204,"version":"3.49.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1016\/s0006-3223(99)00092-x","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T20:41:41Z","timestamp":1027629701000},"page":"8-21","source":"Crossref","is-referenced-by-count":241,"title":["Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia"],"prefix":"10.1016","volume":"47","author":[{"given":"Wayne S","family":"Fenton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Hibbeln","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Knable","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0006-3223(99)00092-X_BIB1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1192\/bjp.127.6.591","article-title":"Effect of ADP on PGE1 formation in blood platelets from patients with depression, mania and schizophrenia","volume":"127","author":"Abdulla","year":"1975","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB2","first-page":"4","article-title":"Phospholipase A2 activity in serum of neuroleptic-naive psychiatric inpatients","volume":"26","author":"Albers","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1203\/00006450-199001000-00023","article-title":"Docosahexaenoic acid is the preferred dietary n-3 fatty acid for the development of the brain and retina","volume":"27","author":"Anderson","year":"1990","journal-title":"Pediatr Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB4","series-title":"Handbook of Essential Fatty Acid Biology; Biochemistry, Physiology, and Behavioral Neurobiology","first-page":"3","article-title":"Permeability of the blood-brain barrier to circulating free fatty acids","author":"Banks","year":"1997"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0920-9964(91)90014-I","article-title":"Fatty acids in plasma phospholipids and cholesterol esters from identical twins concordant and discordant for schizophrenia","volume":"6","author":"Bates","year":"1991","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1600-0447.1988.tb06388.x","article-title":"Fat consumption and schizophrenia","volume":"78","author":"Christensen","year":"1988","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/schbul\/23.4.663","article-title":"Evaluation of treatment resistant schizophrenia","volume":"23","author":"Conley","year":"1997","journal-title":"Schizophr Bull"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0022-2275(20)43209-2","article-title":"Dietary effects on brian fatty acid composition","volume":"31","author":"Connor","year":"1990","journal-title":"J Lipid Research"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-1781(79)90029-5","article-title":"Analgesia to pain stimuli in schizophrenia and its reversal by naltrexone","volume":"1","author":"Davis","year":"1979","journal-title":"Psychiatry Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0006-3223(94)90613-0","article-title":"31Phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia","volume":"36","author":"Deicken","year":"1994","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0920-9964(94)00036-8","article-title":"Correlation between left frontal phospholipids and Wisconsin Card Sort Test performance in schizophrenia","volume":"14","author":"Deicken","year":"1995","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB12","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1046\/j.1471-4159.1996.66041582.x","article-title":"Alpha-linolenic acid deficiency alters age-related changes of dopaminergic and serotonergic neurotransmission in the rat frontal cortex","volume":"66","author":"Delion","year":"1996","journal-title":"J Neurochem"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB13","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1093\/jn\/124.12.2466","article-title":"Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotonergic neurotransmission in rats","volume":"124","author":"Delion","year":"1994","journal-title":"J Nutr"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB14","unstructured":"Department of Health and Human Services, Food and Drug Administration (1997):Substances Affirmed as Generally Recognized as Safe: Menhaden Oil. Federal Register June 5, 1997; 62:30751\u201330757."},{"key":"10.1016\/S0006-3223(99)00092-X_BIB15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0920-9964(98)00016-4","article-title":"Red cell membrane fatty acids, cytosolic phospholipase-A2 and schizophrenia","volume":"31","author":"Doris","year":"1998","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB16","doi-asserted-by":"crossref","unstructured":"Drug Therapy Bulletin (1996):Increasing Fish Oil Intake-Any Net Benefits?34:8.","DOI":"10.1136\/dtb.1996.34860"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB17","first-page":"359","article-title":"Possible association of schizophrenia with a disturbance in prostaglandin metabolism","volume":"6","author":"Feldberg","year":"1976","journal-title":"Psychiatr Med"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB18","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/0006-3223(86)90321-5","article-title":"Niacin-induced flush as a measure of prostaglandin activity in alcoholics and schizophrenics","volume":"21","author":"Fiedler","year":"1986","journal-title":"Biol Psychiatr"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0006-2952(92)90015-B","article-title":"Schizophrenic patients treated with high dose phenothiazine or thioxanthene become deficient in polyunsaturated fatty acids in their thrombocytes","volume":"44","author":"Fischer","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB20","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1021\/bi00352a015","article-title":"Correlation between acetylcholine receptor function and structural properties of membranes","volume":"25","author":"Fong","year":"1986","journal-title":"Biochem J"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0952-3278(96)90154-4","article-title":"Phospholipase A2 and the hypofrontality hypothesis of schizophrenia","volume":"55","author":"Gattaz","year":"1996","journal-title":"Prostaglandins Leukotrienes Essent Fatty Acids"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB22","first-page":"495","article-title":"Increased serum phospholipase A activity in schizophrenia","volume":"28","author":"Gattaz","year":"1990","journal-title":"Biol Psychiatr"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0006-3223(87)90164-8","article-title":"Increased plasma phospholipase-A activity in schizophrenic patients","volume":"22","author":"Gattaz","year":"1987","journal-title":"Biol Psychiatr"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0920-9964(94)00060-L","article-title":"Increased platelet phospholipase A2 activity in schizophrenia","volume":"16","author":"Gattaz","year":"1995","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB25","first-page":"565","article-title":"Cerebrospinal fluid prostaglandin E in depression, mania, and schizophrenia compared to normals","volume":"18","author":"Gerner","year":"1983","journal-title":"Biol Psychiatr"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0952-3278(96)90139-8","article-title":"Membrane fatty acids, niacin flushing and clinical parameters","volume":"55","author":"Glen","year":"1996","journal-title":"Prostaglandins Leukotrienes Essent Fatty Acids"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0920-9964(94)90084-1","article-title":"A red blood cell membrane abnormality in a subgroup of schizophrenic patients","volume":"12","author":"Glen","year":"1994","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB28","first-page":"91","article-title":"Fatty acids and cell signal transduction","volume":"9","author":"Graber","year":"1994","journal-title":"J Lipid Mediat"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00005053-198201000-00002","article-title":"Simultaneous tests of many hypotheses in exploratory research","volume":"170","author":"Grove","year":"1982","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ajcn\/62.1.1","article-title":"Dietary polyunsaturated fatty acids and depression","volume":"62","author":"Hibbeln","year":"1995","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB31","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1176\/ajp.154.12.1683","article-title":"Synaptic elimination, neurodevelopment and the mechanism of hallucinated \u201cvoices\u201d in schizophrenia","volume":"154","author":"Hoffman","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB32","first-page":"302","article-title":"A trial of evening primrose oil in the treatment of chronic schizophrenia","volume":"12","author":"Holman","year":"1983","journal-title":"J Orthomol Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB33","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(77)92228-0","article-title":"Schizophrenia as a prostaglandin deficiency disease","volume":"I","author":"Horrobin","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB34","first-page":"54","article-title":"Schizophrenia","volume":"32","author":"Horrobin","year":"1980","journal-title":"Biomedicine"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0952-3278(92)90063-O","article-title":"The relationship between schizophrenia and essential fatty acid and eicosanoid metabolism","volume":"46","author":"Horrobin","year":"1992","journal-title":"Prostaglandins Leukotriene Essent Fatty Acids"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0920-9964(97)00151-5","article-title":"The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia","volume":"30","author":"Horrobin","year":"1998","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1017\/S0033291700006619","article-title":"Prostaglandins and schizophrenia","volume":"8","author":"Horrobin","year":"1978","journal-title":"Psychol Med"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB38","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0920-9964(97)82614-X","article-title":"Clozapine","volume":"24","author":"Horrobin","year":"1997","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB39","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0006-3223(91)90235-E","article-title":"Fatty acid levels in the brains of schizophrenics and normal controls","volume":"30","author":"Horrobin","year":"1991","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB40","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/0006-3223(89)90216-3","article-title":"Essential fatty acids in plasma phospholipids in schizophrenia","volume":"25","author":"Horrobin","year":"1989","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0920-9964(96)00031-X","article-title":"Genetic variant near cytosolic phospholipase A2 associated with schizophrenia","volume":"21","author":"Hudson","year":"1996","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB42","first-page":"507","article-title":"The niacin challenge test","volume":"41","author":"Hudson","year":"1997","journal-title":"Biol Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0952-3278(96)90156-8","article-title":"Phospholipases","volume":"55","author":"Hudson","year":"1996","journal-title":"Prostaglandins Leukotriene Essent Fatty Acids"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB44","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/syn.890130311","article-title":"CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia","volume":"13","author":"Hudson","year":"1993","journal-title":"Synapse"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB45","first-page":"457","article-title":"Prostaglandin E1 treatment of schizophrenia","volume":"19","author":"Kaiya","year":"1984","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB46","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0006-3223(91)90291-S","article-title":"Essential and other fatty acids in plasma from schizophrenics and normal individuals from Japan","volume":"30","author":"Kaiya","year":"1991","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB47","series-title":"Clinical and Pharmacological Studies in Psychiatric Disorders","first-page":"202","article-title":"Prostaglandin E1 treatment of schizophrenia","author":"Kaiya","year":"1985"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF01255817","article-title":"Elevated plasma prostaglandin E2 levels in schizophrenia","volume":"77","author":"Kaiya","year":"1989","journal-title":"J Neural Transm"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB49","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0022-2275(20)37132-7","article-title":"Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue","volume":"38","author":"Katan","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB50","first-page":"99A","article-title":"Altered membrane phospholipids in fibroblasts from schizophrenic patients","volume":"33","author":"Kelkar","year":"1993","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0165-1781(93)90032-C","article-title":"Erythrocyte membrane phospholipids in psychotic patients","volume":"49","author":"Keshavan","year":"1993","journal-title":"Psychiatry Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB52","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0090-6980(90)90115-C","article-title":"Formation of 15-lipoxygenase product from docosahexaenoic acid (22:6w3) by human platelets","volume":"40","author":"Kim","year":"1990","journal-title":"Prostaglandins"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB53","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/schbul\/21.4.645","article-title":"Vocational rehabilitation in schizophrenia","volume":"21","author":"Lehman","year":"1995","journal-title":"Schizophr Bull"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0952-3278(96)90140-4","article-title":"The niacin challenge test in schizophrenia","volume":"55","author":"Lin","year":"1996","journal-title":"Prostaglandins Leukotriene Essent Fatty Acids"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB55","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archpsyc.1983.01790040059008","article-title":"CSF prostaglandin levels in depressed and schizophrenic patients","volume":"40","author":"Linnoila","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB56","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0010-440X(77)80003-5","article-title":"Schizophrenia and intercurrent physical illness","volume":"18","author":"Lipper","year":"1997","journal-title":"Compr Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB57","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1085\/jgp.104.4.645","article-title":"Lysophospholipids modulate channel function by altering the mechanical properties of lipid bilayers","volume":"104","author":"Lundbaek","year":"1994","journal-title":"J Gen Physiol"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB58","first-page":"313","article-title":"Fatty acids, cytokines and major depression (editorial)","volume":"43","author":"Maes","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0920-9964(95)00049-6","article-title":"Free radical pathology and antioxidant defense in schizophrenia","volume":"19","author":"Mahadik","year":"1996","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB60","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0920-9964(94)90048-5","article-title":"Plasma membrane phospholipid and cholesterol distribution in skin fibroblasts from drug-naive patients at the onset of psychosis","volume":"13","author":"Mahadik","year":"1994","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-1781(96)02899-5","article-title":"Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients","volume":"63","author":"Mahadik","year":"1996","journal-title":"Psychiatry Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB62","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0952-3278(96)90147-7","article-title":"Utilization of precursor essential fatty acids in culture by skin fibroblasts from schizophrenic patients and normal controls","volume":"55","author":"Mahadik","year":"1996","journal-title":"Prostaglandins Leukotriene Essen Fatty Acids"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB63","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/j.1471-4159.1990.tb04929.x","article-title":"Effect of in vivo modulation of membrane docosahexaenoic acid levels on the dopamine-dependent adenylate cyclase activity in the rat retina","volume":"55","author":"Malnoe","year":"1990","journal-title":"J Neurochem"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB64","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJM195903192601203","article-title":"Occurrence of painless acute surgical disorders in psychotic patients","volume":"260","author":"Marchand","year":"1969","journal-title":"New Eng J Med"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB65","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.51.1.26","article-title":"MRI evidence that docosahexaenoic acid ethyl ester improves myelination in generalized peroxisomal disorders","volume":"51","author":"Martinez","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB66","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0140-6736(80)90553-X","article-title":"Increased content of immunoreactive prostaglandin E in cerebrospinal fluid of patients with schizophrenia","volume":"1","author":"Mathe","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB67","series-title":"Biochemistry","author":"Mathews","year":"1996"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB68","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1192\/bjp.170.4.334","article-title":"The Nithsdale schizophrenia surveys 16. Breast feeding and schizophrenia","volume":"170","author":"McCreadie","year":"1997","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB69","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0920-9964(95)00084-4","article-title":"Schizophrenic symptoms and dietary intake of n-3 fatty acids (letter to the editor)","volume":"18","author":"Mellor","year":"1995","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB70","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1445-5994.1974.tb03183.x","article-title":"Absence of rheumatoid arthritis in schizophrenia","volume":"4","author":"Mellsop","year":"1974","journal-title":"Aust New Zealand J Med"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB71","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/355722a0","article-title":"Potentiation of NMDA receptor currents by arachidonic acid","volume":"355","author":"Miller","year":"1992","journal-title":"Nature"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB72","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1615\/CritRevImmunol.v17.i3-4.10","article-title":"Regulatory functions of phospholipase A2","volume":"17","author":"Murakami","year":"1997","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB73","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0952-3278(96)90150-7","article-title":"Essential fatty acids and abnormal involuntary movements in the general male population","volume":"55","author":"Nilsson","year":"1996","journal-title":"Prostaglandins Leukotriene Essent Fatty Acids"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB74","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0006-3223(93)90157-9","article-title":"Elevated PLA2 activity in schizophrenics and other psychiatric patients","volume":"34","author":"Noponen","year":"1993","journal-title":"Biol Psych"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB75","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0022-510X(79)90023-6","article-title":"Fatty acid profiles in mental disease. Part 1. Linolenate variations in schizophrenia","volume":"43","author":"Obi","year":"1979","journal-title":"J Neurol Sci"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB76","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0022-3956(95)00001-L","article-title":"Depleted red cell membrane essential fatty acids in drug treated schizophrenic patients","volume":"29","author":"Peet","year":"1995","journal-title":"J Psychiatr Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB77","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archpsyc.1994.03950080077012","article-title":"Arachidonic acid","volume":"51","author":"Peet","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB78","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0952-3278(96)90148-9","article-title":"Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation","volume":"55","author":"Peet","year":"1996","journal-title":"Prostaglandins Leukotriene Essent Fatty Acids"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB79","doi-asserted-by":"crossref","unstructured":"Peet M, Mellor J (1998): Double-blind placebo controlled trial of n-3 polyunsaturated fatty acids as an adjunct to neuroleptics. Presented at the 9th Schizophrenia Winter Workshop, Davos, Switzerland.","DOI":"10.1016\/S0920-9964(97)88713-0"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/schbul\/19.1.35","article-title":"31P nuclear magnetic resonance spectroscopy","volume":"19","author":"Pettegrew","year":"1993","journal-title":"Schizophr Bull"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB81","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/archpsyc.1991.01810300075011","article-title":"Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex using in vivo phosphorus 31 nuclear magnetic resonance spectroscopy","volume":"48","author":"Pettegrew","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB82","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1093\/jn\/117.10.1663","article-title":"Ingestion of fish oil or a derived n-3 fatty acid concentrate containing eicosapentaenoic acid (EPA) affects fatty acid compositions of individual phospholipids of rat brain, sciatic nerve and retina","volume":"117","author":"Philbrick","year":"1987","journal-title":"J Nutr"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB83","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/ajcn\/63.6.925","article-title":"Effect of n-3 polyunsaturated fatty acid intake on phospholipid fatty acid composition in plasma and erythrocytes","volume":"63","author":"Prisco","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB84","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/archpsyc.55.2.188","article-title":"Sustained remission of positive and negative symptoms of schizophrenia after treatment with eicosapentaenoic acid (letter)","volume":"55","author":"Puri","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB85","doi-asserted-by":"crossref","unstructured":"Reisbick S, Neuringer M (1997): Omega-3 fatty acid deficiency and behavior: a critical review and directions for future research. In: Yehuda S, Mostofsky D, Editors.Handbook of Essential Fatty Acid Biology; Biochemistry, Physiology, and Behavioral Neurobiology. New Jersey: Humana Press, Inc. pp 397\u2013426.","DOI":"10.1007\/978-1-4757-2582-7_17"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB86","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0031-9384(90)90149-X","article-title":"Polydipsia in rhesus monkeys deficient in omega-3 fatty acids","volume":"47","author":"Reisbick","year":"1990","journal-title":"Physiol Behav"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB87","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archpsyc.1997.01830170113015","article-title":"Increased phospholipid breakdown in schizophrenia","volume":"54","author":"Ross","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB88","series-title":"Psychopharmacology","first-page":"759","article-title":"Phospholipid and prostaglandin hypotheses of schizophrenia","author":"Rotrosen","year":"1987"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB89","first-page":"837","article-title":"The major psychoses and neuroses as omega-3 essential fatty acid deficiency syndrome","volume":"16","author":"Rudin","year":"1981","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB90","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/0006-3223(91)90202-W","article-title":"Niacin test in schizophrenia and affective illness","volume":"29","author":"Rybakowski","year":"1991","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB91","series-title":"New Protective Roles for Selected Nutrients","first-page":"109","article-title":"Omega-3 fatty acids","author":"Salem","year":"1989"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB92","first-page":"211","article-title":"Alcohol, fatty acids and diet","volume":"13","author":"Salem","year":"1989","journal-title":"Alcohol Health Res World"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB93","doi-asserted-by":"crossref","unstructured":"Salem N Jr, Kim HY, Yergey JA (1986): Docosahexaenoic acid: membrane function and metabolism. In: Simopoulos A, Kaifer R, Martin R, editors.Health Effects of Polyunsaturated Fatty Acids in Seafoods. Orlando, FL: Academic Press, pp 263\u2013317.","DOI":"10.1016\/B978-0-12-644360-8.50019-4"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB94","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/09687689509038508","article-title":"The nervous system has an absolute molecular species requirement for proper function","volume":"12","author":"Salem","year":"1995","journal-title":"Mol Membr Biol"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB95","series-title":"World Review of Nutrition and Dietetics","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000422334","article-title":"Are omega-3 fatty acids essential nutrients for mammals?","author":"Salem","year":"1993"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB96","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1046\/j.1471-4159.1994.62062437.x","article-title":"Lipoxygenation of docosahexaenoic acid by the rat pineal body","volume":"62","author":"Sawazaki","year":"1994","journal-title":"J Neurochem"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB97","doi-asserted-by":"crossref","unstructured":"Shah S, Vankar GK, Telang SD, Ramchand CN, Peet M (1998): Eicosapentaenoic Acid (EPA) As An Adjunct In The Treatment Of Schizophrenia. Presented at the 9th Schizophrenia Winter Workshop, Davos.","DOI":"10.1016\/S0920-9964(97)88706-3"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB98","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0925-4927(94)90016-7","article-title":"Correlations of phosphomonoesters measured by phosphorus-31 magnetic resonance spectroscopy in the frontal lobes and negative symptoms in schizophrenia","volume":"55","author":"Shioiri","year":"1994","journal-title":"Psychiatry Res Neuroimaging"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB99","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archpsyc.1995.03950170073010","article-title":"An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy","volume":"52","author":"Stanley","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0920-9964(94)90044-2","article-title":"Membrane phospholipid metabolism and schizophrenia","volume":"13","author":"Stanley","year":"1994","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB101","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0952-3278(96)90151-9","article-title":"Dyskinesias and their treatment with essential fatty acids","volume":"55","author":"Vaddadi","year":"1996","journal-title":"Prostaglandins Leukotrienes Essent Fatty Acids"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB102","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0161-4630(79)80011-7","article-title":"Penicillin and essential fatty acid supplementation in schizophrenia","volume":"2","author":"Vaddadi","year":"1979","journal-title":"Prostaglandins Med"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB103","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0165-1781(89)90146-7","article-title":"A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia","volume":"27","author":"Vaddadi","year":"1989","journal-title":"Psychiatry Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB104","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/BF00180839","article-title":"A controlled trial of prostaglandin E1 precursor in chronic neuroleptic resistant schizophrenic patients","volume":"88","author":"Vaddadi","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0920-9964(95)00095-X","article-title":"Schizophrenia, tardive dyskinesia and essential fatty acids","volume":"20","author":"Vaddadi","year":"1996","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB106","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s11745-997-0089-x","article-title":"Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men","volume":"32","author":"Vidgren","year":"1997","journal-title":"Lipids"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB107","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/schbul\/17.4.669","article-title":"Negative association between schizophrenia and rheumatoid arthritis","volume":"17","author":"Vinogradov","year":"1991","journal-title":"Schizophr Bull"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB108","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0149-7634(05)80180-0","article-title":"Do essential fatty acids play a role in behavioral development?","volume":"16","author":"Wainwright","year":"1992","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB109","doi-asserted-by":"crossref","unstructured":"Wainwright PE (1997): Essential fatty acids and behavior: Is there a role for the eicosanoids? In: Yehuda S, Mostofsky D, Editors.Handbook of Essential Fatty Acid Biology; Biochemistry, Physiology, and Behavioral Neurobiology. New Jersey: Humana Press, Inc. pp 299\u2013341.","DOI":"10.1007\/978-1-4757-2582-7_14"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB110","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0920-9964(97)00100-X","article-title":"Niacin skin flush in schizophrenia","volume":"29","author":"Ward","year":"1998","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB111","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/archpsyc.1991.01810300090013","article-title":"Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls","volume":"48","author":"Williamson","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB112","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0006-3223(86)90274-X","article-title":"Niacin skin flush is not diagnostic of schizophrenia","volume":"21","author":"Wilson","year":"1986","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB113","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1046\/j.1471-4159.1994.62041432.x","article-title":"Characterization of the influence of unsaturated free fatty acids on brain GABA\/benzodiazepine receptor binding in vitro","volume":"62","author":"Witt","year":"1994","journal-title":"J Neurochem"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB114","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1176\/ajp.143.7.912","article-title":"Essential fatty acid supplementation in tardive dyskinesia","volume":"143","author":"Wolkin","year":"1986","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0920-9964(94)90014-0","article-title":"Red blood cell membrane dynamics in schizophrenia. I. Membrane fluidity","volume":"11","author":"Yao","year":"1994","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB116","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0920-9964(94)90046-9","article-title":"Red blood cell dynamics in schizophrenia III. Correlation of fatty acid abnormalities with clinical measures","volume":"13","author":"Yao","year":"1994","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB117","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0165-1781(95)02832-3","article-title":"Abnormal incorporation of arachidonic acid into platelets of drug-free patients with schizophrenia","volume":"60","author":"Yao","year":"1996","journal-title":"Psychiatry Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB118","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0920-9964(94)90045-0","article-title":"Red blood cell membrane dynamics in schizophrenia. II. Fatty acid composition","volume":"13","author":"Yao","year":"1994","journal-title":"Schizophr Res"},{"key":"10.1016\/S0006-3223(99)00092-X_BIB119","series-title":"Handbook of Essential Fatty Acid Biology; Biochemistry, Physiology, and Behavioral Neurobiology","first-page":"427","article-title":"Effects of essential fatty acid preparation (SR-3) on brain lipids, biochemistry, and behavioral and cognitive functions","author":"Yehuda","year":"1997"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000632239900092X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000632239900092X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T16:40:53Z","timestamp":1620751253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000632239900092X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":119,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["S000632239900092X"],"URL":"https:\/\/doi.org\/10.1016\/s0006-3223(99)00092-x","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2000,1]]}}}